The HDAC inibitors trichostatin A (TSA) and Quisinostat (JNJ-2648158) increase angulin-1/LSR, decrease CLDN-2, promote G1 arrest and prevented the migration of lung adenocarcinoma A549 cells [101]. This evidence concerns the gene LSR and lung adenocarcinoma.